您要查找的是不是：
- Adevir dipivoxil 阿得福韦酯
- Objective: To establish a method for determination of the residual solvents in ade fovir dipivoxil. 目的:建立阿德福韦酯中残留溶剂的含量测定方法。
- Domestic adefovir dipivoxil(daiding made in China)10 mg dail orally were administered for 52w in group B(46 cases). B组46例服用国产阿德福韦酯(代丁)10m g每天1次,52周。
- In this paper the synthesis of adefovir dipivoxil was introduced,the study and the improvement of the process also discussed. 介绍了阿德福韦酯的合成工艺,并对工艺进行了研究和改进。从最基本的化工原料开始,进行了阿德福韦双酯的全合成。
- Fufangbiejiaruanganpian united Adefovir Dipivoxil treatment of chronic hepatitis B could significantly improve the effect of anti-fibrosis. 复方鳖甲软肝片联合阿得福韦酯治疗慢性乙型肝炎能显著提高抗肝纤维化的治疗效果，值得临床推广使用。
- One of the two had hepatocellular carcinoma and died of hepatic failure at week 125; the other received adefovir dipivoxil (Hepsera) and is doing well. 两名中一位因为癌变在125周的时候肝脏衰竭死亡;另外一位接受阿迪治疗;表现良好.
- Objective To establish a non-aqueous titration method to determine adefovir dipivoxil standard, and prepare the authentic sample of the compound. 目的建立阿德福韦酯对照品含量测定的非水滴定法,以解决无商品标准品的难题。
- Early use of adefovir dipivoxil or entecavir should be considered in patients with pre-existing cirrhosis when they have resisted to lamivudine. 有肝硬化基础患者一旦发生耐药变异，应及时使用能治疗耐药变异的阿德福韦或恩替卡韦。
- Adefovir dipivoxil was recently approved for the treatment of wild-type and lamivudine-resistant hepatitis B virus (HBV) infection. 阿得福韦是最近被批准用于治疗野生型和拉米夫定抵抗型乙型肝炎病毒感染的一种新药。
- The company has developed the series of API like Candesartan Cilexetil , Valsartan , Irbesartan , Gliquidone ,Indapamide, Tibolone ,Adefovir Dipivoxil ,Argatroban , etc. 已开发原料药包括坎地沙坦酯，缬沙坦，厄贝沙坦，格列喹酮，吲达帕胺，替勃龙，阿德福韦酯，阿加曲班等。
- Objective To investigate the efficacy and safety of adefovir dipivoxil (ADV, DAIDINGTM) for Chinese chronic hepatitis B patients with lamivudine (LAM) resistance. 目的研究阿德福韦酯片对拉米夫定耐药慢性乙型肝炎患者的疗效和安全性。
- A rapid and simple method for the determination of adefovir dipivoxil and its related substances by micellar electrokinetic chromatography was developed. 采用胶束电动毛细管色谱法对阿德福韦酯及其有关物质进行了快速分离与测定,并对电泳条件进行了优化。
- Some patients receiving adefovir dipivoxil( Hepsera) at the approved dose of10 mg daily for the treatment of chronic hepatitis B virus( HBV) infection have a suboptimal virological response characterized by a slow and moderate decrease in HBV replication. 有些接受阿德福韦核准每天10毫克药量治疗慢性乙肝感染的患者常出现缓慢，中度减低病毒复制的不佳抗病毒效应。
- Prognosis of chronic hepatitis B has been improved significantly because of the clinical application of nucleoside/nucleotide analogues, such as lamivudine, adefovir dipivoxil, entecavir. 拉米夫定、阿德福韦酯和恩替卡韦等核苷/核苷酸类似物的临床应用，大大改善了慢性乙型肝炎的预后。
- Domestic adefovir dipivoxil(daiding) 阿德福韦酯
- Keywords Hepatitis B virus;Genotype;therapy;Adefovir dipivoxil; 肝炎病毒;乙型;基因型;治疗;阿德福韦酯;
- Keywords adefovir dipivoxil;safety;tolerance;phase I trial; 阿德福韦酯;安全性;耐受性;I期临床试验;
- Keywords Adefovir dipivoxil;Hepatitis B virus;Mutation; 阿德福韦;乙型肝炎病毒;变异;
- Keywords Hepatitis B;adefovir dipivoxil;correlation factor; 慢性乙型肝炎;阿德福韦酯;相关因素;
- Keywords Entecavir;Adeforvir dipivoxil;Chronic hepatitis B;Short-term efficacy; 恩替卡韦;阿德福韦酯;慢性乙型肝炎;近期疗效;
